Product approval information is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia B (congenital factor IX deficiency or Christmas disease)
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2uaFru5
No comments:
Post a Comment